Literature DB >> 9676744

Transgenic acetylcholinesterase induces enlargement of murine neuromuscular junctions but leaves spinal cord synapses intact.

C Andres1, S Seidman, R Beeri, R Timberg, H Soreq.   

Abstract

Acetylcholinesterase (AChE) produced by spinal cord motoneurons accumulates within axo-dendritic spinal cord synapses. It is also secreted from motoneuron cell bodies, through their axons, into the region of neuromuscular junctions, where it terminates cholinergic neurotransmission. Here we show that transgenic mice expressing human AChE in their spinal cord motoneurons display primarily normal axo-dendritic spinal cord cholinergic synapses in spite of the clear excess of transgenic over host AChE within these synapses. This is in contrast to our recent observation that a modest excess of AChE drastically affects the structure and long-term functioning of neuromuscular junctions in these mice although they express human AChE in their spinal cord, but not muscle. Enlarged muscle endplates with either exaggerated or drastically shortened post-synaptic folds then lead to a progressive neuromotor decline and massive amyotrophy (Andres et al., 1997). These findings demonstrate that excess neuronal AChE may cause distinct effects on spinal cord and neuromuscular synapses and attribute the late-onset neuromotor deterioration observed in AChE transgenic mice to neuromuscular junction abnormalities.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9676744     DOI: 10.1016/s0197-0186(97)00121-6

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  7 in total

1.  Synaptogenesis and myopathy under acetylcholinesterase overexpression.

Authors:  E Lev-Lehman; T Evron; R S Broide; E Meshorer; I Ariel; S Seidman; H Soreq
Journal:  J Mol Neurosci       Date:  2000 Feb-Apr       Impact factor: 3.444

2.  Chronic acetylcholinesterase overexpression induces multilevelled aberrations in mouse neuromuscular physiology.

Authors:  Noa Farchi; Hermona Soreq; Binyamin Hochner
Journal:  J Physiol       Date:  2003-01-01       Impact factor: 5.182

3.  Chronic neuropsychological sequelae of cholinesterase inhibitors in the absence of structural brain damage: two cases of acute poisoning.

Authors:  Lola Roldán-Tapi; Antonia Leyva; Francisco Laynez; Fernando Sánchez Santed
Journal:  Environ Health Perspect       Date:  2005-06       Impact factor: 9.031

4.  Presymptomatic treatment with acetylcholinesterase antisense oligonucleotides prolongs survival in ALS (G93A-SOD1) mice.

Authors:  Marc Gotkine; Gotkine Marc; Leah Rozenstein; Rozenstein Leah; Ofira Einstein; Einstein Ofira; Oded Abramsky; Abramsky Oded; Zohar Argov; Argov Zohar; Hanna Rosenmann; Rosenmann Hanna
Journal:  Biomed Res Int       Date:  2013-12-22       Impact factor: 3.411

5.  Interaction of acetylcholinesterase with neurexin-1β regulates glutamatergic synaptic stability in hippocampal neurons.

Authors:  Yun-Yan Xiang; Haiheng Dong; Burton B Yang; John F Macdonald; Wei-Yang Lu
Journal:  Mol Brain       Date:  2014-03-05       Impact factor: 4.041

6.  Serum acetyl cholinesterase as a biomarker of arsenic induced neurotoxicity in sprague-dawley rats.

Authors:  Anita K Patlolla; Paul B Tchounwou
Journal:  Int J Environ Res Public Health       Date:  2005-04       Impact factor: 3.390

7.  TDP-43 Regulation of AChE Expression Can Mediate ALS-Like Phenotype in Zebrafish.

Authors:  Maria-Letizia Campanari; Anca Marian; Sorana Ciura; Edor Kabashi
Journal:  Cells       Date:  2021-01-22       Impact factor: 6.600

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.